For: | Tajiri K, Shimizu Y. Recent advances in the management of pruritus in chronic liver diseases. World J Gastroenterol 2017; 23(19): 3418-3426 [PMID: 28596678 DOI: 10.3748/wjg.v23.i19.3418] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i19/3418.htm |
Number | Citing Articles |
1 |
Jing Song, Dehai Xian, Lingyu Yang, Xia Xiong, Rui Lai, Jianqiao Zhong. Pruritus: Progress toward Pathogenesis and Treatment. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/9625936
|
2 |
Melika Marani, Vrinda Madan, Thomas K. Le, Junwen Deng, Kevin K. Lee, Emily Z. Ma, Shawn G. Kwatra. Dysregulation of the Skin–Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis. Genes 2024; 15(2): 146 doi: 10.3390/genes15020146
|
3 |
Sanjay Saint, Vineet Chopra, Thy Thy Do. The Saint-Chopra Guide to Inpatient Medicine. 2018; : 507 doi: 10.1093/med/9780190862800.003.0090
|
4 |
Jyh-Jou Chen, Yen-Cheng Chiu, Pei-Lun Lee, Hung-Da Tung, Hung-Chih Chiu, Shih-Chieh Chien, Pin-Nan Cheng. Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for genotype 6 chronic hepatitis C. Journal of the Formosan Medical Association 2022; 121(11): 2265 doi: 10.1016/j.jfma.2022.04.020
|
5 |
Ezgi KARADAĞ, Yaren TOKYÜREK, Mesut AKARSU. The effect of baby oil applied to pruritus areas on pruritus, fatigue and anxiety in cirrhosis patients with pruritus. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi 2022; 8(1): 27 doi: 10.30569/adiyamansaglik.995781
|
6 |
Andres F. Carrion, Jordan D. Rosen, Cynthia Levy. Understanding and Treating Pruritus in Primary Biliary Cholangitis. Clinics in Liver Disease 2018; 22(3): 517 doi: 10.1016/j.cld.2018.03.005
|
7 |
A.B. Hussain, R. Samuel, V.S. Hegade, D.E. Jones, N.J. Reynolds. Pruritus secondary to primary biliary cholangitis: a review of the pathophysiology and management with phototherapy. British Journal of Dermatology 2019; 181(6): 1138 doi: 10.1111/bjd.17933
|
8 |
Helen T. Smith, Andrea Ribeiro de Souza, April H. Thompson, Megan M. McLaughlin, John J. Dever, Julie A. Myers, Jing Voon Chen. Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review. Digestive Diseases and Sciences 2023; 68(6): 2710 doi: 10.1007/s10620-023-07862-z
|
9 |
Usha Gungabissoon, Helen T Smith, Robyn von Maltzahn, John Logie, Jolyon Fairburn-Beech, Liyuan Ma, Dhirishiya P, Ashleigh McGirr, Jake N Hunnicutt, Christopher L Rowe, Meghan Tierney, Haley S Friedler. Pruritus in primary biliary cholangitis is under-recorded in patient medical records. BMJ Open Gastroenterology 2024; 11(1): e001287 doi: 10.1136/bmjgast-2023-001287
|
10 |
Antonio Moreno-Loro, Álvaro Giráldez, Fernando Jiménez, Ignacio López-Bueno, Alberto Pérez-Ramírez, Manuel Romero-Gómez. Novel approaches in the medical management of compensated cirrhosis. Expert Review of Gastroenterology & Hepatology 2024; 18(6): 239 doi: 10.1080/17474124.2024.2358149
|
11 |
Floris W. Haijer, Cornelis B. Van Vliet, Marjolein G. J. Brusse-Keizer, Job A. M. Van der Palen, Marjo J. Kerbert-Dreteler, Jeroen J. Kolkman, Dirk Uhlmann. Gamma-Glutamyl Transferase: A Friend against Cholestatic Itch? A Retrospective Observational Data Analysis in Patients with Extrahepatic Cholestasis. International Journal of Hepatology 2023; 2023: 1 doi: 10.1155/2023/2903171
|
12 |
A. Thébaut, D. Debray, E. Gonzales. An update on the physiopathology and therapeutic management of cholestatic pruritus in children. Clinics and Research in Hepatology and Gastroenterology 2018; 42(2): 103 doi: 10.1016/j.clinre.2017.08.007
|
13 |
Taiwo O. Elufioye, Solomon Habtemariam. Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action. Biomedicine & Pharmacotherapy 2019; 112: 108600 doi: 10.1016/j.biopha.2019.108600
|
14 |
Ayesha Shah, James Tabibian, Cynthia Buness, Gerald J. Holtmann. An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis. Digestive Diseases and Sciences 2024; 69(10): 3608 doi: 10.1007/s10620-024-08497-4
|
15 |
Jennifer Pate, Juilo A Gutierrez, Catherine T Frenette, Aparna Goel, Sonal Kumar, Richard A Manch, Edward A Mena, Paul J Pockros, Sanjaya K Satapathy, Kidist K Yimam, Robert G Gish. Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel. BMJ Open Gastroenterology 2019; 6(1): e000256 doi: 10.1136/bmjgast-2018-000256
|
16 |
Frederick M. Karrer, Jonathan P. Roach. Error traps and culture of safety in biliary atresia. Seminars in Pediatric Surgery 2019; 28(3): 135 doi: 10.1053/j.sempedsurg.2019.04.017
|
17 |
Huasheng Yu, Tianjun Zhao, Simin Liu, Qinxue Wu, Omar Johnson, Zhaofa Wu, Zihao Zhuang, Yaocheng Shi, Luxin Peng, Renxi He, Yong Yang, Jianjun Sun, Xiaoqun Wang, Haifeng Xu, Zheng Zeng, Peng Zou, Xiaoguang Lei, Wenqin Luo, Yulong Li. MRGPRX4 is a bile acid receptor for human cholestatic itch. eLife 2019; 8 doi: 10.7554/eLife.48431
|
18 |
Kazunori Yoh, Hiroki Nishikawa, Hirayuki Enomoto, Yoshinori Iwata, Akio Ishii, Yukihisa Yuri, Noriko Ishii, Yuho Miyamoto, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Hiroko Iijima, Shuhei Nishiguchi. Effect of nalfurafine hydrochloride in patients with chronic liver
disease with refractory pruritus on sleep disorders: a study protocol for
single-arm, prospective, interventional study. BMJ Open Gastroenterology 2017; 4(1): e000177 doi: 10.1136/bmjgast-2017-000177
|
19 |
Fatemeh Forouzanfar, Paul C. Guest, Tannaz Jamialahmadi, Amirhossein Sahebkar. Natural Products and Human Diseases. Advances in Experimental Medicine and Biology 2021; 1328: 489 doi: 10.1007/978-3-030-73234-9_34
|
20 |
Ashley Vander Does, Cynthia Levy, Gil Yosipovitch. Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments. American Journal of Clinical Dermatology 2022; 23(5): 647 doi: 10.1007/s40257-022-00710-2
|
21 |
Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev. Mechanism for development of malnutrition in primary biliary cholangitis. World Journal of Meta-Analysis 2022; 10(3): 81-98 doi: 10.13105/wjma.v10.i3.81
|
22 |
Ranya Selim, Joseph Ahn. Pruritus in Chronic Liver Disease. Clinics in Liver Disease 2023; 27(1): 47 doi: 10.1016/j.cld.2022.08.011
|
23 |
Chenyi Xu, Rensong Yue, Xuelian Lv, Shengnan Wang, Mengmeng Du. Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis: A systematic review and meta-analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.835991
|
24 |
Eleni Karatza, Brandon Swift, Fernando Carreño, Sumanta Mukherjee, Linda Casillas, Janelle Lennie, James Fettiplace, Megan M. McLaughlin, Andreas E. Kremer. Serum bile acid change correlates with improvement in pruritus in patients with primary biliary cholangitis receiving linerixibat. Liver International 2024; 44(9): 2293 doi: 10.1111/liv.15982
|
25 |
Xiaojiaoyang Li, Runping Liu, Luyong Zhang, Zhenzhou Jiang. The emerging role of AMP-activated protein kinase in cholestatic liver diseases. Pharmacological Research 2017; 125: 105 doi: 10.1016/j.phrs.2017.09.002
|
26 |
Robyn von Maltzahn, Marlyn J. Mayo, Helen T. Smith, April Thompson, Sugato Das, Andrea Ribeiro de Souza, Edoardo Lisi, Cynthia Levy, Megan M. McLaughlin, David Jones. Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial. Journal of Patient-Reported Outcomes 2024; 8(1) doi: 10.1186/s41687-024-00722-y
|
27 |
Tarika Sivakumar, Kris V Kowdley. Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life. Hepatic Medicine: Evidence and Research 2021; : 83 doi: 10.2147/HMER.S256692
|
28 |
Igor Lamotkin, Daniil Korabelnikov, Andrey Lamotkin. Chronic itch associated with systemic origin in patients of a multidisciplinary hospital. Russian Medical and Social Journal 2019; 1(2): 57 doi: 10.35571/RMSJ.2019.2.005
|
29 |
Babina Sanjel, Won-Sik Shim. Recent advances in understanding the molecular mechanisms of cholestatic pruritus: A review. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(12): 165958 doi: 10.1016/j.bbadis.2020.165958
|
30 |
Vishwajit Kode, Kidist K. Yimam. Cholestatic Pruritus: Pathophysiology, Current Management Approach, and Emerging Therapies. Current Hepatology Reports 2024; 23(1): 123 doi: 10.1007/s11901-024-00638-7
|
31 |
Atsushi Tanaka, Masanori Atsukawa, Keiji Tsuji, Kazuo Notsumata, Akari Suyama, Hiroshi Ito, Sugato Das, Robyn von Maltzahn, Megan M. McLaughlin. Japanese subgroup analysis of GLIMMER: A global Phase IIb study of linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis. Hepatology Research 2023; 53(7): 629 doi: 10.1111/hepr.13895
|
32 |
Rati Chkheidze, Ranjit Joseph, James Burner, Karen Matevosyan. Plasma exchange for the management of refractory pruritus of cholestasis: A report of three cases and review of literature. Journal of Clinical Apheresis 2018; 33(3): 412 doi: 10.1002/jca.21573
|
33 |
Yukihisa Fujinaga, Tadashi Namisaki, Yuki Tsuji, Junya Suzuki, Koji Murata, Soichi Takeda, Hiroaki Takaya, Takashi Inoue, Ryuichi Noguchi, Yuki Fujimoto, Masahide Enomoto, Norihisa Nishimura, Koh Kitagawa, Kosuke Kaji, Hideto Kawaratani, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji. Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis. International Journal of Molecular Sciences 2022; 23(17): 9814 doi: 10.3390/ijms23179814
|
34 |
Jordan Daniel Rosen, Anna Chiara Fostini, Gil Yosipovitch. Diagnosis and Management of Neuropathic Itch. Dermatologic Clinics 2018; 36(3): 213 doi: 10.1016/j.det.2018.02.005
|
35 |
Shuhei Yoshikawa, Takeharu Asano, Mina Morino, Keita Matsumoto, Hitomi Kashima, Yudai Koito, Takaya Miura, Yuko Takahashi, Rumiko Tsuboi, Takehiro Ishii, Haruka Otake, Junichi Fujiwara, Masanari Sekine, Takeshi Uehara, Kazuhito Yuhashi, Satohiro Matsumoto, Shinichi Asabe, Hiroyuki Miyatani, Hirosato Mashima. Pruritus is common in patients with chronic liver disease and is improved by nalfurafine hydrochloride. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-82566-w
|
36 |
Ebehiwele Ebhohon, Raymond T. Chung. Systematic review: efficacy of therapies for cholestatic pruritus. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231172829
|